Selling Opioids Is Not A Public Nuisance For Three Reasons, Oklahoma State Appeals Court Rules
Executive Summary
Overturning a $465m verdict against J&J, Oklahoma Supreme Court rejects claim opioid sales violated a public right. It says a manufacturer does not have control of its product once it is sold and cannot be held perpetually liable for its products.
You may also be interested in...
Teva Inks Texas Opioids Settlement And Eyes J&J’s Nationwide ‘Formula’
Teva CEO Kåre Schultz has spoken at great length of the firm’s current standing with opioid-related matters, days after it reached a deal valued at $225m to resolve claims in the state of Texas. A nationwide deal is still top of the Israeli firm’s agenda, with a rough estimate of $3bn-$4bn suggested.
Opioid Jury Verdict May Change Settlement Equation For Sponsors
New York jury finds that Teva and distributor Anda violated state’s public nuisance law in their marketing and distribution of opioids. Such claims had been rejected by two previous courts and the verdict in this case shows the challenges companies face in ongoing litigation.
US FDA Cast As Culpable Player In Opioid Epidemic In Hulu’s Dopesick Series
Show depicts former agency officials approving OxyContin labeling that enabled Purdue to market it as nonaddictive and subsequently refusing pleas to restrict its use.